The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy

Summary

The hypothesis of this study is that pregabalin, 150 mg bid, will reduce general daytime pain in patients diagnosed with diabetic peripheral neuropathy and that it will also reduce the level of pain associated with walking. Consequently, it is hypothesized that the reduction in pain will result in an increase in the amount of walking they do during the day, improvements in their gait, balance, risk of falls and sleep patterns.

Timeline

Start

2011-01

Primary completion

2013-12

Completion

2013-12

Drugs

Indications